document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center this exhibit been redacted subject confidential treatment request redacted material marked with been filed separately with security exchange commission style margin margin bottom font size font family time roman align center license agreement style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center shionogi nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center amylin pharmaceutical style margin margin bottom font size font family time roman align center july nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center license agreement style margin margin bottom text indent font size font family time roman this license agreement this agreement made entered into effective july nbsp effective date between shionogi nbsp corporation organized under japan with principal place business dochomachi chome chuo osaka japan shionogi amylin pharmaceutical delaware corporation with principal place business towne centre drive diego california amylin amylin shionogi sometimes referred herein individually party collectively party style margin margin bottom font size font family time roman align center recital style margin margin bottom text indent font size font family time roman whereas amylin owns control certain patent right know relating proprietary protein referred generally leptins style margin margin bottom text indent font size font family time roman whereas shionogi pharmaceutical company engaged research development manufacturing commercialization pharmaceutical compound capability development manufacture commercialization pharmaceutical compound style margin margin bottom text indent font size font family time roman whereas shionogi desire obtain from amylin amylin willing grant shionogi exclusive license develop manufacture subject certain limitation commercialize certain leptin product japan south korea taiwan term condition forth herein style margin margin bottom text indent font size font family time roman whereas shionogi desire obtain from amylin amylin willing supply shionogi requirement leptin development commercialization licensed territory either drug substance final drug product term condition separate supply agreement entered into between party forth herein style margin margin bottom text indent font size font family time roman therefore based premise mutual covenant obligation forth below intending bound hereby party agree follows style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center definition style margin margin bottom text indent font size font family time roman purpose this agreement following term shall have meaning forth below style margin margin bottom text indent font size font family time roman active component mean active pharmaceutical ingredient other than leptin which performs identifiable therapeutic prophylactic function when combined with leptin product style margin margin bottom text indent font size font family time roman affiliate mean with respect party entity that directly indirectly through more intermediary control controlled under common control with style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman such party purpose this definition control mean with correlative meaning term controlled under common control with possession direct indirect power cause direction management policy applicable entity whether through ownership fifty percent nbsp more voting security such entity contract otherwise entity will affiliate purpose this agreement only long satisfies definition forth above this section style margin margin bottom text indent font size font family time roman amgen agreement mean license agreement between amylin amgen dated february nbsp redacted copy which attached this agreement exhibit style margin margin bottom text indent font size font family time roman amylin shall have meaning ascribed such term opening paragraph this agreement style margin margin bottom text indent font size font family time roman amylin indemnitees shall have meaning ascribed such term section style margin margin bottom text indent font size font family time roman claim mean claim allegation suit complaint action legal proceeding style margin margin bottom text indent font size font family time roman combination product mean product sold behalf shionogi affiliate sublicensee that contains leptin combination with more active component style margin margin bottom text indent font size font family time roman commercialize commercialization mean those activity relating promotion marketing distribution sale licensed product including phase trial equivalent clinical trial conducted following regulatory approval market pharmaceutical product style margin margin bottom text indent font size font family time roman commercially reasonable effort mean level effort resource commonly used pharmaceutical industry develop obtain regulatory approval protect intellectual property relating commercialize product consistent with effort similarly situated pharmaceutical company would typically devote product similar stage product life similar market potential profit potential strategic value resulting from research effort based information condition then prevailing including without limitation efficacy product competitiveness alternative product marketplace patent other proprietary position product likelihood regulatory approval given regulatory structure involved likelihood adequate reimbursement commercially reasonable effort shall determined country country each country including territory basis particular licensed product anticipated that level effort will change over time reflecting change status licensed product country including territory involved style margin margin bottom text indent font size font family time roman confidential information party mean confidential proprietary information received otherwise obtained other party from such party affiliate pursuant this agreement other than that portion such information that style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman hereafter becomes generally available public through fault receiving party affiliate entity that obtained such information material from receiving party style margin margin bottom text indent font size font family time roman receiving party affiliate already posse evidenced written record prior receipt thereof from disclosing party style margin margin bottom text indent font size font family time roman obtained without restriction from third party that legal right disclose same receiving party affiliate style margin margin bottom text indent font size font family time roman been independently developed receiving party affiliate without application confidential information disclosing party demonstrated competent written proof style margin margin bottom text indent font size font family time roman control mean with respect nbsp material document item information method data other know nbsp intellectual property right possession whether ownership license other than license granted pursuant this agreement party affiliate ability grant other party access ownership license sublicense provided this agreement under such item right without violating term agreement other arrangement with third party time such party would first required hereunder grant other party such access ownership license sublicense applicable style margin margin bottom text indent font size font family time roman default mean with respect particular party that nbsp representation warranty such party forth herein shall have been untrue material respect when made nbsp such party such party affiliate sublicensee shall have materially breached this agreement nbsp such party failed other party payment owed other party before last when such payment style margin margin bottom text indent font size font family time roman dollar mean united state dollar shall interpreted accordingly style margin margin bottom text indent font size font family time roman drug product mean finished dosage form that contains drug substance generally necessarily association with other active inactive ingredient necessarily labeled packaged style margin margin bottom text indent font size font family time roman drug substance mean leptin bulk active pharmaceutical ingredient form ready formulation into final drug product style margin margin bottom text indent font size font family time roman mean united state food drug administration successor thereto style margin margin bottom text indent font size font family time roman field mean treatment lipodystrophy congenital absence leptin human style margin margin bottom text indent font size font family time roman financial event shall have meaning ascribed section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman mean equivalent work nbsp professional employee full time nbsp year consisting least total year excluding vacation holiday style margin margin bottom text indent font size font family time roman rate mean adjusted annual basis accordance with consumer price index style margin margin bottom text indent font size font family time roman gaap mean united state generally accepted accounting principle style margin margin bottom text indent font size font family time roman mean investigational drug application defined successor regulation style margin margin bottom text indent font size font family time roman indemnified party shall have meaning ascribed section nbsp style margin margin bottom text indent font size font family time roman indemnifying party shall have meaning ascribed section style margin margin bottom text indent font size font family time roman launch date mean date which licensed product first sold shionogi affiliate sublicensee third party country territory after regulatory approval licensed product been granted such country style margin margin bottom text indent font size font family time roman leptin mean methuleptin polypeptide having amino acid sequence forth exhibit this agreement style margin margin bottom text indent font size font family time roman license shall have meaning ascribed section style margin margin bottom text indent font size font family time roman licensed know mean know trade secret experimental data formula experimental procedure clinical clinical data other confidential proprietary information that nbsp controlled amylin affiliate nbsp directly related field necessary development sale licensed product field territory clarity without limitation restricted manufacturing information excluded from licensed know style margin margin bottom text indent font size font family time roman licensed patent right mean leptin patent right rockefeller patent right applicable style margin margin bottom text indent font size font family time roman leptin patent right mean patent right limited leptin extent controlled amylin following style margin margin bottom text indent font size font family time roman patent patent application forth part exhibit style margin margin bottom text indent font size font family time roman patent application that continuation divisionals patent application described above style margin margin bottom text indent font size font family time roman issued unexpired patent resulting from application described nbsp nbsp above style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman issued unexpired reissue reexamination renewal extension patent described nbsp above style margin margin bottom text indent font size font family time roman licensed product mean preparation containing leptin intended field clarity term licensed product excludes product that antagonizes leptin receptor style margin margin bottom text indent font size font family time roman licensed technology mean licensed patent right licensed know style margin margin bottom text indent font size font family time roman loss mean cost expense including without limitation reasonable legal expense attorney judgment liability fine damage assessment other loss style margin margin bottom text indent font size font family time roman marketing approval application mean appropriate application registration submitted appropriate regulatory authority particular country territory seek regulatory approval such country style margin margin bottom text indent font size font family time roman sale mean with respect applicable time period revenue recognized accordance with gaap consistently applied that invoiced otherwise received from sale other commercial disposition licensed product sold transferred used shionogi affiliate sublicensees length transaction third party during such time period total following charge expense extent actually incurred allowed with respect such sale disposition nbsp trade cash prompt payment quantity discount invoiced price nbsp return allowance rebate chargebacks other allowance payment government agency nbsp retroactive price reduction applicable sale such licensed product nbsp reasonable management paid group purchasing organization managed care entity nbsp freight shipping packing insurance nbsp nonrecoverable sale other based sale price excluding income extent paid shionogi affiliate sublicensees reimbursed third party provided that amount subsection nbsp nbsp aggregate exceed total revenue recognized such time period sale licensed product style margin margin bottom font size font family time roman sale deduction taken above shall determined accordance with gaap style margin margin bottom font size font family time roman disposal licensed product licensed product clinical clinical trial without charge given free sample including sample card coupon distributed indigent program shall included sale style margin margin bottom font size font family time roman upon sale other disposal licensed product that should included within sale consideration other than exclusively monetary consideration bona fide length term then purpose calculating sale under this agreement such licensed product shall deemed sold exclusively money average sale price during applicable reporting period generally achieved such licensed product country which such sale other disposal occurred when such licensed product sold alone with other product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman case licensed product that combination product sale such combination product shall calculated multiplying actual sale such combination product fraction where invoice price licensed product which contain active component sold separately total invoice price active component combination product sold separately country country basis active component combination product sold separately said country sale purpose determining royalty combination product shall calculated multiplying actual sale such combination product fraction where invoice price licensed product which contain active component sold separately invoice price combination product neither licensed product which contain active component active component combination product sold separately given country party shall determine sale such combination product mutual agreement based relative contribution licensed product which contain active component active component combination product style margin margin bottom font size font family time roman event licensed product sold with more other product service single price together multiple product offering sale such multiple product offering shall calculated multiplying actual sale such multiple product offering fraction where invoice price licensed product sold separately total invoice price other product multiple product offering sold separately country country basis other product multiple product offering sold separately said country sale purpose determining royalty multiple product offering shall calculated multiplying actual sale such multiple product offering fraction where invoice price licensed product sold separately invoice price multiple product offering neither licensed product other product sold separately given country party shall determine sale such multiple product offering mutual agreement based relative contribution licensed product excluding other product each other product multiple product offering style margin margin bottom text indent font size font family time roman phase trial mean clinical trial pharmaceutical product initiated country approved indication after receipt regulatory approval such product such indication such country delineate additional information about such product risk benefit optimal style margin margin bottom text indent font size font family time roman procedural default shall have meaning ascribed section style margin margin bottom text indent font size font family time roman regulatory approval mean approval including supplement amendment post approval price approval license registration authorization national supra national regional state local regulatory agency department bureau commission council other governmental entity necessary distribution sale licensed product country territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman regulatory authority mean regulatory agency department bureau commission council other governmental entity involved granting approval development manufacturing marketing reimbursement pricing licensed product country territory style margin margin bottom text indent font size font family time roman regulatory document mean regulatory document filing correspondence with regulatory authority annual report amendment thereto related leptin licensed product style margin margin bottom text indent font size font family time roman restricted manufacturing information mean information controlled amylin affiliate that relates directly manufacture leptin including limited information contained section applicable regulatory document covering leptin style margin margin bottom text indent font size font family time roman rockefeller license mean that certain license agreement between rockefeller university amgen dated april nbsp amended redacted copy which included amgen agreement style margin margin bottom text indent font size font family time roman rockefeller patent mean following patent right extent controlled amylin style margin margin bottom text indent font size font family time roman patent patent application identified part exhibit style margin margin bottom text indent font size font family time roman patent application that claim priority patent patent application identified part exhibit hereto extent that claim directed leptin field including divisional continuation whole part application based patent application described above style margin margin bottom text indent font size font family time roman foreign application territory corresponding patent application described nbsp above style margin margin bottom text indent font size font family time roman issued unexpired patent resulting from application described nbsp nbsp above style margin margin bottom text indent font size font family time roman issued unexpired reissue reexamination renewal extension patent described nbsp above style margin margin bottom text indent font size font family time roman rockefeller patent shall include patent right subpart nbsp nbsp above solely extent such patent right licensed amylin amgen under amgen agreement style margin margin bottom text indent font size font family time roman royalty term mean licensed product licensed product country country basis period from launch date particular licensed product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman specific country until later nbsp expiration last expire valid claim covering such licensed product such country nbsp expiration market exclusivity period granted regulatory authority with respect such licensed product such country designation orphan product nbsp nbsp year from launch date such licensed product such country style margin margin bottom text indent font size font family time roman royalty term amgen mean licensed product licensed product country country basis period from launch date particular licensed product specific country until later nbsp expiration last expire valid claim covering such licensed product such country nbsp expiration market exclusivity period granted regulatory authority with respect such licensed product such country designation orphan product nbsp nbsp year from launch date such licensed product such country style margin margin bottom text indent font size font family time roman royalty term rockefeller mean licensed product licensed product country country basis period from launch date particular licensed product specific country until expiration last expire valid claim covering such licensed product such country style margin margin bottom text indent font size font family time roman shionogi shall have meaning ascribed such term opening paragraph this agreement style margin margin bottom text indent font size font family time roman shionogi product data mean data other result generated clinical trial other study licensed product conducted behalf shionogi affiliate sublicensee style margin margin bottom text indent font size font family time roman shionogi indemnitees shall have meaning ascribed such term section style margin margin bottom text indent font size font family time roman shionogi know mean know trade secret experimental data formula experimental procedure clinical clinical data other confidential proprietary information that nbsp controlled shionogi affiliate nbsp necessary useful development manufacture sale licensed product style margin margin bottom text indent font size font family time roman shionogi patent mean patent patent application that nbsp controlled shionogi affiliate nbsp claim cover development manufacture sale licensed product style margin margin bottom text indent font size font family time roman specification mean specification drug substance drug product established amylin consultation with shionogi style margin margin bottom text indent font size font family time roman sublicensee mean sublicensee direct indirect shionogi under shionogi right pursuant section style margin margin bottom text indent font size font family time roman term mean term this agreement forth section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman territory mean japan south korea republic china taiwan style margin margin bottom text indent font size font family time roman third party mean person other than amylin shionogi affiliate either them style margin margin bottom text indent font size font family time roman trademark mean trade name service mark logo trademark whether registered together with goodwill associated therewith renewal extension modification thereto style margin margin bottom text indent font size font family time roman valid claim mean unexpired claim issued patent within licensed patent right that been found unpatentable invalid unenforceable court other authority country patent from which decision appeal taken taken style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center license related right style margin margin bottom text indent font size font family time roman patent license style margin margin bottom text indent font size font family time roman subject term condition this agreement amgen agreement amylin hereby grant shionogi exclusive even amylin license with right grant sublicenses subject shionogi compliance with section nbsp this agreement under leptin patent right solely develop sell have sold offer sale import licensed product territory within field style margin margin bottom text indent font size font family time roman subject term condition this agreement amgen agreement rockefeller license amylin hereby grant shionogi exclusive even amylin sublicense with right grant further sublicenses subject shionogi compliance with section nbsp this agreement term rockefeller license under amylin exclusive right under rockefeller patent solely develop sell have sold offer sale import licensed product territory within field style margin margin bottom text indent font size font family time roman know license subject term condition this agreement including section term both amgen agreement rockefeller license applicable amylin hereby grant shionogi exclusive even amylin license with right grant sublicenses subject shionogi compliance with section nbsp this agreement under licensed know solely develop sell have sold offer sale import licensed product territory within field style margin margin bottom text indent font size font family time roman sublicenses shionogi shall have right grant sublicenses affiliate third party under license right granted section subject other term this article only expressly permitted under this article shionogi grant sublicenses third party under license right granted section nbsp which shall allow grant further sublicenses such third party provided however that such style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman sublicense right third party shall subject prior written consent amylin which shall unreasonably withheld delayed notwithstanding sublicensing part shionogi right obligation hereunder shionogi shall remain responsible full complete performance shionogi obligation duty under this agreement shionogi shall promptly notify amylin granting sublicense hereunder provide amylin copy fully executed agreement under which shionogi granted such sublicense such sublicense shall require sublicensee comply with obligation shionogi contained herein such sublicense shall provide termination sublicense upon termination this agreement shionogi shall include each every sublicense agreement express language that term such sublicense subject term condition obligation this agreement style margin margin bottom text indent font size font family time roman retained right notwithstanding license granted shionogi pursuant section amylin retains right under licensed technology nbsp needed fulfill obligation under this agreement nbsp conduct research development manufacturing commercialization activity with respect product containing leptin other than licensed product nbsp conduct research development manufacturing commercialization activity with respect product containing leptin including licensed product other than field territory outside territory further amgen retains right under licensed technology extent specified amgen agreement further rockefeller retains right under licensed technology extent specified rockefeller license style margin margin bottom text indent font size font family time roman limitation license right expressly excluded from license right granted shionogi section right nbsp practice restricted manufacturing information nbsp manufacture have manufactured drug substance drug product further shionogi hereby covenant agrees that shall affiliate sublicensees shall nbsp practice licensed technology purpose other than expressly permitted license granted section nbsp develop promote market offer sale sell licensed product outside field nbsp market promote sell licensed product outside territory which right expressly exclusively reserved amylin understood agreed that amylin retains exclusively right restricted manufacturing information obligation disclose same shionogi shionogi also covenant that affiliate sublicensees shall time comply with obligation amylin under amgen agreement style margin margin bottom text indent font size font family time roman back option addition termination right forth section nbsp amylin terminate this agreement time with without cause accordance with provision this section nbsp such termination right hereinafter referred back option event amylin exercise back option pursuant this section nbsp amylin shionogi shall negotiate good faith term back option which shall include obligation amylin make time payment shionogi such payment hereinafter referred back option event amylin exercise style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman back option before launch date back option shall amount nbsp least equal amount expense including pocket expense internal shionogi expense such ftes shionogi employee paid amylin amgen rockefeller incurred shionogi developing licensed product such hereinafter referred shionogi sunk cost nbsp more than amount shionogi sunk cost event amylin exercise back option after launch date back option shall total nbsp amount more than amount shionogi sunk cost nbsp amount more than monthly sale licensed product month which back option exercised event amylin shionogi reach agreement amount back option within date amylin notifies shionogi intent exercise back option then amylin will choose independent valuation entity determine amount back option shionogi shall have from date amylin notifies shionogi identity independent valuation entity accept reject such entity event shionogi accepts entity respond within such independent valuation entity shall establish amount back option accordance with parameter forth this section style margin margin bottom text indent font size font family time roman rockefeller license agreement shionogi agrees comply directly with obligation forth rockefeller license including timely paying directly rockefeller university successor assigns royalty payable rockefeller university under term rockefeller license that arise result activity shionogi affiliate sublicensees under this agreement amylin agrees comply directly with obligation amylin under rockefeller license other than obligation which shionogi agrees comply with directly pursuant preceding sentence each amylin shionogi will promptly notify other notice default breach that receives from rockefeller university successor assigns regarding rockefeller license event rockefeller university notifies amylin shionogi default breach under rockefeller license related failure shionogi affiliate sublicensees perform obligation covenant under rockefeller license amylin shall have right obligation take such action make such payment reasonably necessary appropriate cure such default breach shionogi shall promptly reimburse amylin therefor solely extent necessary avoid termination shionogi sublicense under section this agreement termination rockefeller license shionogi shall have right obligation take such action make such payment reasonably necessary appropriate cure default breach amylin obligation under rockefeller license that amylin cured neither party shall terminate amend modify waive right under rockefeller license without prior written consent other party which shall unreasonably withheld delayed failure shionogi perform obligation under this section nbsp shall constitute default under this agreement amylin shall have liability shionogi termination modification rockefeller license arising resulting from failure shionogi affiliate sublicensees abide comply with perform under term condition obligation rockefeller license notwithstanding anything contrary this agreement shionogi agrees that license right granted under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman with respect rockefeller patent rockefeller know rockefeller license subject term condition obligation under rockefeller license amylin agrees take lawful step reasonably necessary requested shionogi permit shionogi exercise enforce amylin right under rockefeller license extent shionogi right under this agreement style margin margin bottom text indent font size font family time roman amgen license agreement shionogi agrees comply directly with obligation forth amgen agreement including timely paying directly amgen successor assigns royalty payable amgen under term amgen agreement that arise result activity shionogi affiliate sublicensees under this agreement amylin agrees comply directly with obligation amylin under amgen agreement other than obligation which shionogi agrees comply with directly pursuant preceding sentence each amylin shionogi will promptly notify other notice default breach that receives from amgen successor assigns regarding amgen agreement event amgen notifies amylin shionogi default breach under amgen agreement related failure shionogi affiliate sublicensees perform obligation covenant under amgen agreement amylin shall have right obligation take such action make such payment reasonably necessary appropriate cure such default breach shionogi shall promptly reimburse amylin therefor solely extent necessary avoid termination shionogi sublicense under section this agreement termination amgen agreement shionogi shall have right obligation take such action make such payment reasonably necessary appropriate cure default breach amylin obligation under amgen agreement that amylin cured neither party shall terminate amend modify waive right under amgen agreement without prior written consent other party which shall unreasonably withheld delayed failure shionogi perform obligation under this section nbsp shall constitute default under this agreement amylin shall have liability shionogi termination modification amgen agreement arising resulting from failure shionogi affiliate sublicensees abide comply with perform under term condition obligation amgen agreement notwithstanding anything contrary this agreement shionogi agrees that license right granted under this agreement subject term condition obligation under amgen agreement amylin agrees take lawful step reasonably necessary requested shionogi permit shionogi exercise enforce amylin right under amgen agreement extent shionogi right under this agreement style margin margin bottom text indent font size font family time roman shionogi license subject term condition this agreement shionogi hereby grant amylin exclusive license sublicense applicable with full right grant sublicenses under shionogi product data shionogi know shionogi patent solely research develop seek regulatory approval promote market offer sale sell product containing leptin outside territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center transfer asset manufacture supply drug substance style margin margin bottom font size font family time roman align center drug product regulatory matter style margin margin bottom text indent font size font family time roman transfer asset style margin margin bottom text indent font size font family time roman licensed know soon reasonably practicable after effective date amylin will provide shionogi copy licensed know applicable regulatory document territory relating field extent then possession clinical data portion licensed know will provided shionogi computer readable transport format where practicable available otherwise printed format other portion licensed know will provided shionogi written form electronically reasonably practicable otherwise hard copy document data from clinical trial applicable field conducted behalf amylin will also provided signed clinical study report data relating field from ongoing clinical trial will also provided written report summary manuscript where available during term information identified that controlled amylin affiliate reasonably necessary development manufacture commercialization licensed product territory field contemplated this agreement should included licensed know provided under this section nbsp previously provided shionogi pursuant this section nbsp then amylin will promptly provide such licensed know shionogi style margin margin bottom text indent font size font family time roman reserved right amylin shall have right review right access right reference right incorporate licensed know including data information regulatory document assigned shionogi satisfy obligation exercise retained right under this agreement style margin margin bottom text indent font size font family time roman manufacture supply drug substance drug product party agree that long amylin developing commercializing leptin amylin shall manufacture have manufactured supply shionogi requirement drug product accordance with term condition separate supply agreement entered into party should drug product conform specification required ministry health labor welfare determined shionogi shionogi expense amylin shall forth commercially reasonable effort facilitate resolution such issue between shionogi third party manufacturer provided however shionogi shall responsible internal external expense associated with such effort forth amylin third party manufacturer except such expense will necessary satisfy requirement commonly requested regulatory authority outside territory style margin margin bottom font size font family time roman promptly after effective date party shall negotiate good faith enter into commercially reasonable clinical supply agreement regarding supply shionogi requirement drug product clinical trial appropriate time prior commercial launch sale licensed product containing leptin territory party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman shall negotiate good faith commercially reasonable commercial supply agreement related agreement including quality agreement regarding supply shionogi requirement drug product commercializing such licensed product shionogi affiliate sublicensees shall manufacture contract with third party manufacture drug substance drug product provided more detail applicable supply agreement shionogi shall amylin transfer price amount drug product delivered shionogi amylin amylin designee such transfer price shall amount agreed amylin shionogi good faith from time time shall amount excess amylin actual fully burdened manufacturing cost drug product delivered event amylin longer developing commercializing leptin nbsp amylin shall arrange shionogi negotiate directly with amgen regarding term under which shionogi contract with appropriate amgen approved contract manufacturing organization shionogi obtain requirement such leptin product field territory under other term this agreement nbsp shionogi agrees commercially reasonable effort expeditiously enter into agreement with such contract manufacturing organization provide shionogi drug substance drug product requirement amylin shall forth commercially reasonable effort assign existing contract shionogi require amylin existing third party manufacturer both drug substance drug product continue supplying shionogi with requirement until shionogi becomes able procure such drug product from such contract manufacturing organization style margin margin bottom text indent font size font family time roman communication with regulatory authority from after effective date except forth this agreement including section nbsp transfer regulatory document shionogi shall responsible contact with regulatory authority with respect licensed product territory within field shionogi request subject amylin personnel being available amylin participate such regulatory discussion such participation paid shionogi rate addition shionogi shall amylin reasonable external expense including travel diem lodging with respect such participation such travel expense will charged accordance with amylin then current travel policy shionogi shall share with amylin regulatory related development information including limited regulatory authority communication protocol submission annual report licensing application reasonable timeframe style margin margin bottom text indent font size font family time roman regulatory filing shionogi shall control legally responsible shall sole expense conduct preparation filing name with appropriate regulatory authority document including inds that necessary conduct clinical study licensed product application regulatory approval that necessary market sell licensed product field territory reasonably requested shionogi amylin shall provide reasonable consultation cooperation shionogi shionogi expense rate such effort including preparation provision document including document specifically required territory support accelerate regulatory filing promptly after submission each such regulatory filing shionogi shall notify amylin writing that such regulatory filing been made shall provide amylin with copy each such filing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman conjunction with such filing shionogi reasonable request amylin shall furnish shionogi amylin sole option directly appropriate regulatory authority such information that nbsp already possession control amylin affiliate nbsp necessary obtain such regulatory approval licensed product such information shall include information manufacturing leptin relates applicable licensed product amylin elect provide such information directly appropriate regulatory authority rather than shionogi amylin shall notify shionogi intent make relevant filing such drug master file accordance with shionogi reasonable direction will provide appropriate authorization letter relevant regulatory authority enable shionogi reference such regulatory filing style margin margin bottom font size font family time roman amylin shall request commercially reasonable effort cause contract manufacturing organization accept site audit premise laboratory where drug substance drug product manufactured tested stored requested regulatory authority shionogi either independent audit conjunction with amylin initiated audit amylin permitted provided that appropriate notice given amylin designate amylin attendee participate audit conducted shionogi shionogi shall responsible cost incurred such independent audit cost incurred involvement amylin initiated audit amylin shall respond independently unless required regulatory authority regulatory correspondence inquiry except with shionogi approval which shall unreasonably withheld addition amylin shall promptly notify shionogi regulatory inspection inquiry including limited inspection amylin premise laboratory forward shionogi copy correspondence from regulatory authority relating licensed product obtain written consent shionogi which shall unreasonably withheld before referring shionogi regulatory correspondence where reasonably practicable shionogi shall given opportunity have representative designee participate during regulatory authority inspection style margin margin bottom text indent font size font family time roman event reporting shionogi shall responsible reporting event defined below associated with development commercialization licensed product territory appropriate regulatory authority accordance with applicable rule regulation shall provide amylin copy such report promptly after filing with regulatory authority additionally event either party receives information regarding event related leptin licensed product such party shall promptly provide other party with such information accordance with separate safety agreement entered into party promptly purpose this section nbsp event shall mean adverse event adverse drug reaction medical device report including without limitation malfunction product failure improper inadequate design manufacturer labeling user error reported during licensed product leptin behalf shionogi affiliate sublicensees customer including without limitation user purchasing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman licensed product using licensed product purchased from foregoing shionogi shall notify amylin immediately information received regarding threatened pending action public authority that affect related safety efficacy other labeling claim leptin product style margin margin bottom text indent font size font family time roman right reference shionogi shall provide amylin writing letter reference granting amylin affiliate sublicensees right reference purpose relating development commercialization product containing leptin outside territory with respect filing with regulatory authority made behalf shionogi affiliate sublicensee territory relating leptin licensed product regulatory approval extent that such filing registration approval relate leptin licensed product needed amylin affiliate sublicensees develop obtain regulatory approval commercialize licensed product outside territory such letter reference shall expressly permit amylin transfer such right affiliate sublicensee allow such entity right reference such filing regulatory approval connection with development commercialization licensed product anywhere outside territory equivalent regulatory authority outside territory requires access certain portion such filing registration approval related leptin licensed product legal regulatory purpose connection with amylin affiliate sublicensees development commercialization effort including without limitation making patent related submission then shionogi shall amylin cost cooperate with such regulatory authority make such portion available regulatory authority legally required amylin submit pursue application regulatory approval amylin affiliate sublicensee solely such purpose style margin margin bottom text indent font size font family time roman recall matter shionogi shall observe conform time with legal requirement order maintain effective system recall from market licensed product used sold territory shionogi will responsible conducting accordance with applicable regulation withdrawal recall licensed product used sold territory except otherwise provided supply agreement between party will provide amylin with reasonable notice under circumstance such intended withdrawal recall appropriate time extent practicable amylin shionogi discus such intended action style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center diligence style margin margin bottom text indent font size font family time roman diligence shionogi shall good faith commercially reasonable effort develop obtain regulatory approval following regulatory approval commercialize protect intellectual property extent shionogi control over protection such intellectual property with respect licensed product territory within field during term shionogi affiliate sublicensees fail satisfy obligation under this section nbsp this agreement such failure shall deemed default style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman report within thirty nbsp after march september each calendar year shionogi shall provide amylin written semi annual report concerning effort regarding development commercialization licensed product territory carried during prior nbsp month planned next nbsp month which semi annual report shall include summary shionogi clinical development activity status shionogi clinical trial then current schedule clinical trial filing regulatory application each country status other approval necessary manufacture market licensed product including pricing reimbursement approval shionogi shall also provide prompt written notice amylin nbsp regulatory approval received licensed product country nbsp launch date each licensed product each country information contained such report notice shall deemed shionogi confidential information style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center consideration payment report style margin margin bottom text indent font size font family time roman license shionogi shall amylin within thirty nbsp after effective date license cash wire transfer immediately available fund into account designated writing amylin such license shall nonrefundable noncreditable against milestone other payment amylin under this agreement style margin margin bottom text indent font size font family time roman milestone payment style margin margin bottom text indent font size font family time roman shionogi shall amylin milestone payment amount forth below within thirty nbsp achievement applicable development event with respect licensed product being developed style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom colspan align center milestone payment bgcolor cceeff style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman addition shionogi shall following time milestone payment within thirty nbsp such calendar quarter which achievement indicated sale milestone made nbsp upon achieving annual sale licensed product territory amount equivalent nbsp upon achieving annual sale licensed product territory amount equivalent provided however that this section nbsp shall applied only during royalty term style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman shionogi shall good faith commercially reasonable effort achieve facilitate cause achievement milestone event forth section nbsp nbsp above such milestone payment shall nonrefundable noncreditable against other payment amylin under this agreement shionogi shall promptly notify amylin writing achievement particular milestone soon practicable after first becoming aware achievement milestone event style margin margin bottom text indent font size font family time roman royalty shionogi shall tiered royalty amylin sale licensed product territory following royalty rate which depend amount sale applicable calendar year style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom align center annual sale valign bottom nbsp nbsp valign bottom align center royalty nbsp rate bgcolor cceeff style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman example annual sale licensed product royalty payable such sale shall follows style margin margin bottom text indent font size font family time roman foregoing royalty shall paid with respect sale licensed product each particular country territory until expiration royalty term applicable such licensed product such country style margin margin bottom text indent font size font family time roman payment amylin royalty obligation shionogi shall directly amylin licensors rockefeller university amgen amount tiered royalty payment licensor royalty payment that amylin owes such licensors pursuant amgen agreement rockefeller license based upon sale licensed product territory table nbsp nbsp forth below illustrative purpose supersede licensor royalty payment forth amgen agreement rockefeller license such payment such licensors amount licensor royalty payment shall made within thirty nbsp receipt invoice from amylin shionogi shall provide amylin written evidence payment such licensor royalty payment amount timely basis promptly after payment made style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman royalty rate rockefeller style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom align center annual sale valign bottom nbsp nbsp valign bottom align center royalty rate bgcolor cceeff style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman example annual sale licensed product royalty payable such sale shall follows style margin margin bottom text indent font size font family time roman foregoing royalty shall paid with respect sale licensed product each particular country territory until expiration royalty term rockefeller applicable such licensed product such country style margin margin bottom text indent font size font family time roman royalty rate amgen style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom align center annual sale valign bottom nbsp nbsp valign bottom align center royalty rate bgcolor cceeff style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom text indent font size font family time roman foregoing royalty shall paid with respect sale licensed product each particular country territory until expiration royalty term amgen applicable such licensed product such country style margin margin bottom text indent font size font family time roman payment report payment amylin hereunder shall made amylin wire transfer electronic fund transfer accordance with payment transfer instruction provided amylin beginning with calendar quarter which launch date first licensed product occurs until expiration shionogi obligation royalty royalty payment report sale licensed product each calendar quarter will calculated delivered amylin under this agreement within thirty nbsp each such calendar quarter unless otherwise specifically provided herein each payment royalty shall accompanied report sale licensed product sufficient detail permit confirmation accuracy royalty payment made including country country basis number licensed product sold gross sale sale licensed product deduction taken from gross sale category forth definition sale arrive sale calculation royalty payable dollar style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman method used calculate royalty exchange rate used total royalty sale licensed product during such calendar quarter shall paid time such report made shionogi will keep complete accurate record pertaining sale other disposition licensed product sufficient detail permit amylin confirm accuracy payment hereunder cost other expense incurred amylin that reimbursable under this agreement amylin shall invoice shionogi more frequently than quarterly such cost reimbursable expense incurred under term this agreement shionogi shall such invoiced amount within thirty nbsp receipt each such invoice style margin margin bottom text indent font size font family time roman exchange rate with respect sale invoiced expense incurred currency other than dollar sale invoiced expense incurred shall converted into dollar equivalent using rate exchange which corresponds rate used invoicing incurring party respective reporting period related recording such sale expense book record that maintained accordance with gaap payment shall made dollar time legal restriction country territory prevent prompt remittance payment with respect sale that country shionogi shall have right option upon written notice amylin make such payment depositing amount thereof local currency amylin account such other designated nominee amylin bank depository such country style margin margin bottom text indent font size font family time roman late payment undisputed amount paid shionogi when under this agreement disputed amount that become subsequently upon resolution such dispute which paid shionogi within fifteen nbsp such resolution shall subject interest from including date payment through including date upon which shionogi made wire transfer immediately available fund into account designated amylin interest rate equal libor london interbank offer rate plus style margin margin bottom text indent font size font family time roman event that rule regulation require shionogi withhold with respect payment made shionogi pursuant this agreement shionogi will notify amylin such withholding requirement prior making payment amylin provide such assistance amylin including provision such documentation required authority reasonably necessary amylin effort claim exemption from reduction such shionogi will accordance with such rule regulation withhold from amount remit such appropriate authority shionogi shall provide amylin original copy official receipt evidencing such obligation together with written evidence payment within thirty nbsp following such payment paid authority shionogi shall provide reasonable assistance amylin obtain refund withheld obtain credit with respect paid style margin margin bottom text indent font size font family time roman audit shionogi shall shionogi shall cause affiliate sublicensees keep complete accurate record underlying revenue expense data relating calculation sale payment necessary ascertain shionogi compliance with this agreement including such record that necessary verify royalty payment owed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman amylin shall have right expense more than once year have independent certified public accountant selected amylin reasonably acceptable shionogi review such record upon reasonable notice which shall than thirty nbsp prior written notice during regular business hour under obligation strict confidence sole purpose verifying basis accuracy payment required made under this agreement within prior thirty nbsp month period calendar year audited more than time notwithstanding foregoing event that shionogi restates earnings such restatement would impact royalty amylin period previously audited shionogi revise report make further payment period which report payment previously provided amylin under section nbsp which report payment reflects material change amount royalty prior period amylin previously audited such period then amylin shall have right audit affected time period solely with respect verifying effect such restatement revision royalty with respect such period shionogi shall receive copy each audit report promptly from amylin should inspection lead discovery discrepancy amylin detriment shionogi shall amount discrepancy within thirty nbsp after being notified thereof amylin shall full cost inspection unless discrepancy greater than five percent which case shionogi shall amylin actual cost charged such accountant such inspection style margin margin bottom text indent font size font family time roman licensor royalty obligation should amylin commercialize leptin other than field territory outside territory amylin shall commercially reasonable effort negotiate agree reduced royalty rate with amgen rockefeller university owed amylin such licensors based sale licensed product such event amylin shall provide shionogi prompt notice such reduced licensor royalty payment such agreed reduced royalty rate with amgen rockefeller university shall applied this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center intellectual property style margin margin bottom text indent font size font family time roman prosecution maintenance style margin margin bottom text indent font size font family time roman amylin licensor applicable will have sole responsibility using reasonable effort discretion expense filing prosecution defense maintenance licensed patent right before patent authority territory including conducting defending interference opposition similar proceeding obtaining maintaining patent extension supplementary protection certificate like with respect licensed patent right patent prosecution amylin will consult with shionogi reasonably regarding such patent prosecution effort shall consider take into account reasonable shionogi comment with regard such effort obligated that amylin will keep shionogi informed progress with regard activity relating patent prosecution extent such progress reasonably relates claim licensed patent right that relate field licensed shionogi style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman under this agreement provided that amylin permitted under relevant agreement amylin shall provide shionogi copy material patent document relating patent prosecution effort relating directly field reasonable time advance proposed filing required response shionogi will have right comment such filing response style margin margin bottom text indent font size font family time roman notwithstanding foregoing shionogi shall have right consulted receive disclosure with regard patent patent application that licensed under rockefeller license amgen agreement only extent amylin such right grant such right shionogi accordance with term rockefeller license amgen agreement applicable style margin margin bottom text indent font size font family time roman each party shall designate lead patent counsel either house mutually agreeable outside firm additionally case amylin lead patent agent patent contact person ongoing patent matter hereunder between amylin shionogi party change such patent contact person from time time written notice delivered other party style margin margin bottom text indent font size font family time roman infringement third party style margin margin bottom text indent font size font family time roman except otherwise provided below amylin shall have first right obligation expense enforce leptin patent right against third party infringers territory within field field infringement event amylin shall elect enforce leptin patent right against field infringement amylin shall control such action provided that shionogi shall expense entitled participate have counsel selected shionogi participate such action provided that amylin will nonetheless control such action time recovery action against field infringement under this section nbsp shall used first reimburse party cost expense including attorney such action equal basis remainder shall belong amylin style margin margin bottom text indent font size font family time roman amylin initiate action against field infringement otherwise cause such field infringement cease within ninety nbsp becoming aware field infringement such field infringement having material negative impact shionogi then shionogi shall have right subject other limitation forth below obligation expense enforce applicable leptin patent right against field infringement provided that amylin have reasonable business justification initiating such action event shionogi shall elect enforce leptin patent right against field infringement shionogi shall control such action provided that amylin shall expense entitled participate have counsel selected amylin participate such action provided that shionogi will nonetheless control such action time recovery action against field infringement under this section nbsp shall used first reimburse party cost expense including attorney such action equal basis remainder shall belong shionogi provided that such remainder shall deemed sale accrued calendar quarter which such recovery occurs which shionogi shall amylin royalty under section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman shionogi shall have right enforce defend patent right covered rockefeller license amgen agreement only extent that amylin such right under rockefeller license amgen agreement with respect thereto convey such right shionogi style margin margin bottom text indent font size font family time roman each party shall promptly notify other party upon becoming aware potential third party infringement licensed patent right style margin margin bottom text indent font size font family time roman neither party shall enter into settlement action under this section nbsp that materially negatively affect other party right interest under this agreement without such other party written consent which consent shall unreasonably withheld delayed style margin margin bottom text indent font size font family time roman defense each party shall promptly notify other party upon receiving written notice potential infringement third party claim action against amylin shionogi their affiliate sublicensees possible infringement third party patent right resulting from development commercialization licensed product territory subject indemnification defense obligation party under article each party shall responsible defending shall control defense such action brought against such party party shall confer with each other cooperate defense such action which both amylin shionogi named party neither party shall enter into settlement action under this section nbsp that materially negatively affect other party right interest under this agreement without such other party written consent which consent shall unreasonably withheld delayed notwithstanding foregoing nothing this section nbsp shall obligate either party defend against action referenced this section nbsp addition connection with such defense shionogi shall confer cooperate with rockefeller university with respect thereto comply with such other obligation required under rockefeller license style margin margin bottom text indent font size font family time roman cooperation each party agrees reasonably cooperate with other party filing prosecution maintenance defense enforcement licensed patent right forth this article including joining action proceeding reasonably requested signing necessary legal paper providing other party with data other information reasonably requested support thereof each party shall keep other party reasonably informed substantive development with respect enforcement defensive action under this article regarding licensed patent right style margin margin bottom text indent font size font family time roman marking licensed product shall marked with patent number issued patent within licensed patent right that cover such licensed product extent permitted country which such marking have notice value against infringers patent style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center representation warranty covenant style margin margin bottom text indent font size font family time roman representation warranty amylin effective date amylin hereby represents warrant shionogi follows style margin margin bottom text indent font size font family time roman corporate existence power amylin corporation duly organized validly existing good standing under state delaware full corporate power authority legal right operate property asset carry business being conducted style margin margin bottom text indent font size font family time roman authority binding agreement amylin corporate power authority legal right enter into this agreement perform obligation hereunder amylin taken necessary corporate action part required authorize execution delivery agreement performance obligation hereunder agreement been duly executed delivered amylin constitutes legal valid binding obligation amylin that enforceable against accordance with term style margin margin bottom text indent font size font family time roman conflict execution delivery performance this agreement amylin conflict with would result breach material agreement instrument understanding oral written which party which bound violate material regulation court governmental body administrative other agency having jurisdiction over style margin margin bottom text indent font size font family time roman patent right amylin right grant license under licensed patent right granted hereunder assigned transferred conveyed licensed right title interest licensed patent right manner inconsistent with term this agreement there pending litigation amylin knowledge written threat litigation that been received amylin been resolved taking license otherwise which alleges that amylin activity with respect licensed patent right leptin have infringed misappropriated intellectual property right third party style margin margin bottom text indent font size font family time roman disclaimer except expressly forth this section material information provided hereunder being provided without representation warranty except expressly forth this section amylin make representation warranty express implied kind including merchantability fitness particular infringement specifically amylin warrant validity enforceability licensed patent right make representation whatsoever with regard scope licensed patent right that licensed patent right licensed know exploited without infringing other patent other intellectual property right third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman representation warranty shionogi effective date shionogi hereby represents warrant amylin follows style margin margin bottom text indent font size font family time roman corporate existence power shionogi corporation duly organized validly existing good standing under japan full corporate power authority legal right operate property asset carry business being conducted style margin margin bottom text indent font size font family time roman authority binding agreement shionogi corporate power authority legal right enter into this agreement perform obligation hereunder shionogi taken necessary corporate action part required authorize execution delivery agreement performance obligation hereunder agreement been duly executed delivered shionogi constitutes legal valid binding obligation shionogi that enforceable against accordance with term style margin margin bottom text indent font size font family time roman conflict execution delivery performance this agreement shionogi conflict with would result breach material agreement instrument understanding oral written which party which bound violate material regulation court governmental body administrative other agency having jurisdiction over style margin margin bottom text indent font size font family time roman disclaimer except expressly forth this section shionogi make representation warranty express implied kind style margin margin bottom text indent font size font family time roman mutual covenant each party hereby covenant other party that will enter into agreement with third party that conflict with this agreement will take action that would prevent from performing obligation under this agreement that would otherwise materially conflict with adversely affect performance obligation under this agreement style margin margin bottom text indent font size font family time roman additional covenant style margin margin bottom text indent font size font family time roman misappropriation infringement shionogi covenant amylin that shionogi shall knowingly misappropriate infringe trade secret patent other intellectual property another party activity develop manufacture commercialize licensed product style margin margin bottom text indent font size font family time roman debarment shionogi covenant amylin that course development commercialization licensed product during term shionogi shall knowingly employee consultant been debarred regulatory authority best shionogi knowledge been subject debarment proceeding regulatory authority amylin covenant shionogi that course manufacturing regulatory activity under section amylin shall knowingly employee consultant been debarred regulatory authority best amylin knowledge been subject debarment proceeding regulatory authority style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman compliance with applicable shionogi covenant comply with statute regulation including statute regulation guidance regulatory authority applicable activity under this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center indemnification style margin margin bottom text indent font size font family time roman indemnification amylin amylin hereby agrees defend hold harmless indemnify shionogi affiliate sublicensees each their respective officer director employee collectively shionogi indemnitees from against loss arising third party claim based upon resulting from nbsp amylin representation warranty forth section nbsp this agreement being untrue material respect when made nbsp amylin failure perform material respect covenant agreement amylin forth this agreement nbsp manufacture supply drug substance drug product shionogi under control amylin provided however such manufacture supply drug substance drug product performed third party such indemnification obligation this romanet nbsp shall only extent that amylin receives indemnification from such third party nbsp amylin gross negligence willful misconduct except each case extent such loss result from gross negligence willful misconduct shionogi indemnitees from breach representation warranty covenant obligation under this agreement shionogi affiliate sublicensees style margin margin bottom text indent font size font family time roman indemnification shionogi shionogi hereby agrees defend hold harmless indemnify amylin affiliate each their respective officer director employee collectively amylin indemnitees from against loss arising third party claim based upon resulting from nbsp shionogi representation warranty forth section nbsp this agreement being untrue material respect when made nbsp shionogi affiliate failure perform material respect covenant agreement shionogi forth this agreement nbsp development manufacture labeling packaging commercialization licensed product shionogi affiliate sublicensees except each case extent such loss result from gross negligence willful misconduct amylin indemnitees from breach representation warranty covenant obligation under this agreement amylin style margin margin bottom text indent font size font family time roman indemnification procedure each party amylin behalf amylin indemnitees shionogi behalf shionogi indemnitees will promptly notify other party when becomes aware claim which indemnification sought hereunder eligible indemnified claim person seeking indemnification indemnified party shall nbsp provide party required indemnify such person indemnifying party with prompt written notice claim giving rise indemnification obligation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman under this article provided that failure provide such prompt notice shall relieve indemnifying party obligation under this article except extent indemnifying party actually prejudiced thereby nbsp provide indemnifying party with exclusive ability defend with reasonable cooperation indemnified party against claim nbsp settle admit materially prejudice claim without indemnifying party prior written consent indemnified party shall reasonably cooperate with indemnifying party indemnifying party expense defense claim notwithstanding foregoing indemnified party shall have right participate have counsel participate action proceeding which indemnified party seek indemnified indemnifying party such participation shall indemnified party expense unless nbsp indemnifying party indemnified party shall have mutually agreed retention such counsel nbsp named party such proceeding including impleaded party include both indemnifying party indemnified party representation both party same counsel would inappropriate actual potential differing interest between them indemnifying party obligation under section nbsp case shall apply extent indemnified party failure take reasonable action mitigate loss indemnifying party shall settle compromise consent entry judgment with respect claim without prior written consent indemnified party which will unreasonably withheld delayed style margin margin bottom text indent font size font family time roman insurance shionogi shall expense procure maintain during term period five nbsp year thereafter insurance policy policy including product liability insurance adequate cover obligation hereunder which consistent with normal business practice prudent company similarly situated such insurance shall construed create limit shionogi liability with respect indemnification obligation under this article shionogi shall provide amylin with written evidence such insurance upon request shionogi shall provide amylin with prompt written notice cancellation renewal material change such insurance self insurance which could materially adversely affect right amylin hereunder shall commercially reasonable effort provide such notice least thirty nbsp prior such cancellation renewal material change shionogi insurance hereunder shall primary with respect obligation which shionogi liable hereunder amylin insurance shall contributing with respect obligation which amylin indemnified shionogi hereunder amylin insurance hereunder shall primary with respect obligation which amylin liable hereunder shionogi insurance shall contributing with respect obligation which shionogi indemnified amylin hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center confidentiality style margin margin bottom text indent font size font family time roman treatment confidential information party agree that during term period five nbsp year after this agreement expires terminates party receiving confidential information other party shall nbsp maintain confidence such confidential information nbsp disclose such confidential information third party without prior written consent disclosing party except otherwise permitted this article nbsp such confidential information purpose other than performance exercise right under this agreement style margin margin bottom text indent font size font family time roman authorized disclosure style margin margin bottom text indent font size font family time roman based upon advice legal counsel skilled subject matter party required disclose specific confidential information other party comply with applicable regulation legal process order government authority court competent jurisdiction party disclose such confidential information only entity person required receive such disclosure provided however that party required disclose such confidential information shall nbsp extent permitted such regulation process order rule first have given prompt event than five nbsp business advance notice such other party enable seek available exemption from limitation such disclosure requirement shall reasonably cooperate such effort other party nbsp furnish only portion confidential information which legally required disclosed nbsp reasonable effort secure confidential protection such confidential information nbsp continue perform obligation confidentiality this article style margin margin bottom text indent font size font family time roman each party disclose confidential information other party regulatory authority extent such disclosure reasonably necessary regulatory filing required development commercialization licensed product addition each party disclose confidential information other party other than restricted manufacturing information extent such disclosure reasonably necessary following instance filing prosecuting patent permitted this agreement disclosure rockefeller university amgen extent necessary fulfill obligation under rockefeller license amgen agreement applicable accordance with this agreement rockefeller license amgen agreement disclosure sublicensees potential sublicensees licensee potential licensee amylin contractor employee consultant need know such information development manufacture commercialization licensed product banker lawyer accountant agent other third party connection with diligence similar investigation potential third party investor confidential financing document provided that such sublicensee licensee contractor employee consultant banker lawyer accountant agent third party bound obligation confidentiality least restrictive those forth herein case each disclosure party making such disclosure shall reasonable effort obtain confidential treatment such disclosure shall disclose confidential information other party other than reasonably necessary style margin margin bottom text indent font size font family time roman publicity term agreement party shall treat existence material term this agreement confidential shall disclose such information third party without prior written consent other party except provided section nbsp treating such information confidential information purpose section nbsp party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman agree that upon execution this agreement shortly thereafter either party issue press release which shall subject prior review approval other party unreasonably withheld delayed except such press release otherwise required applicable applicable stock exchange requirement neither amylin shionogi shall issue cause publication other press release public announcement with respect transaction contemplated this agreement without express prior approval other party which approval shall unreasonably withheld delayed provided that each amylin shionogi make public statement response question press analyst investor those attending industry conference financial analyst call issue press release long such public statement press release inconsistent with prior public disclosure public statement approved other party pursuant this section nbsp which reveal public information about other party reasonable opinion party legal counsel public announcement transaction contemplated agreement required applicable applicable stock exchange requirement then extent permissible such party will provide other with notice reasonable under circumstance event than nbsp prior disclosure such intended announcement will consult with other party with respect nature scope required announcement which shall limited information reasonably required disclosed addition foregoing with respect complying with disclosure requirement security exchange commission other regulatory agency connection with required filing this agreement with such agency party shall consult with another concerning which term this agreement shall requested redacted public disclosure agreement agency each party shall seek confidential treatment agency public disclosure agreement agency definition leptin licensed product field exhibit dollar amount forth herein shionogi required disclose this agreement term hereof shionogi shall give amylin reasonable advance notice such required disclosure shall address accommodate amylin reasonable comment regarding extent such disclosure style margin margin bottom text indent font size font family time roman injunctive relief given nature confidential information competitive damage that would result party upon unauthorized disclosure transfer confidential information third party party agree that monetary damage sufficient remedy breach this article addition other remedy party shall entitled seek specific performance injunctive other equitable relief remedy breach threatened breach this article style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center term termination style margin margin bottom text indent font size font family time roman term this agreement shall expire upon expiration last royalty term licensed product with respect which shionogi license under this agreement unless earlier terminated pursuant this article upon expiration royalty term with respect licensed product country payment full amount owed amylin style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman amylin licensors hereunder with respect such licensed product such country license granted section such licensed product such country shall become exclusive fully paid irrevocable shall survive expiration early termination this agreement notwithstanding foregoing supply agreement described section nbsp shall expire term style margin margin bottom text indent font size font family time roman termination style margin margin bottom text indent font size font family time roman termination bankruptcy insolvency party terminate this agreement written notice event following occurs with respect other party each financial event nbsp such party file petition bankruptcy make general assignment benefit creditor otherwise acknowledges writing insolvency adjudged bankrupt such party nbsp fails assume this agreement such bankruptcy proceeding within after filing nbsp assumes assigns this agreement third party nbsp such party into placed process complete liquidation nbsp trustee receiver appointed substantial portion such party business such trustee receiver discharged within after appointment nbsp case proceeding shall have been commenced other action taken against such party bankruptcy seeking liquidation reorganization dissolution winding arrangement composition readjustment debt other relief under bankruptcy insolvency reorganization similar jurisdiction hereafter effect dismissed converted into voluntary proceeding governed clause nbsp above within after filing nbsp there shall have been issued warrant attachment execution distraint similar process against substantial part property such party such event shall have continued period none following occurred nbsp dismissed nbsp bonded manner reasonably satisfactory other party nbsp discharged style margin margin bottom text indent font size font family time roman termination shionogi default upon default shionogi under this agreement amylin notify shionogi such default require that shionogi cure such default which cure period shall shorter than amylin notice default payment obligation amylin notice other default event shionogi shall have cured default applicable cure period amylin terminate this agreement immediately upon written notice shionogi style margin margin bottom text indent font size font family time roman termination amylin default upon default amylin under this agreement shionogi notify amylin writing such default require that amylin cure such default within shionogi notice event amylin shall have cured default cure period shionogi terminate this agreement immediately upon written notice amylin style margin margin bottom text indent font size font family time roman termination shionogi shionogi determines that feasible shionogi pursue development launch sale licensed product scientific technical regulatory commercial reason including limited nbsp lack efficacy licensed product nbsp adverse event licensed product nbsp marketability licensed product nbsp reason related licensed patent right coverage validity shionogi style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman shall notify amylin writing such determination provide amylin with pertinent information with respect thereto following receipt such notice from shionogi within party shall discus situation good faith following such discussion shionogi terminate this agreement upon prior written notice style margin margin bottom text indent font size font family time roman other termination following shall immediate material breach this agreement that shionogi shall have right cure nbsp financial event shionogi nbsp lawsuit reexamination protest proceeding equivalent filed shionogi affiliate sublicensee against amylin affiliate amgen affiliate seeking declaratory judgment determination that claim licensed patent right invalid unenforceable narrower scope otherwise patentable procedural default upon occurrence financial event procedural default amylin shall have right terminate this agreement time upon written notice shionogi style margin margin bottom text indent font size font family time roman effect termination style margin margin bottom text indent font size font family time roman upon termination this agreement pursuant section nbsp solely amylin style margin margin bottom text indent font size font family time roman license assignment granted hereunder shionogi shall terminate revert exclusively amylin sublicenses granted shionogi under right license granted shionogi under this agreement shall terminate unless except extent that amylin agrees writing such sublicenses shall terminate upon termination this agreement instead shall become direct license with amylin style margin margin bottom text indent font size font family time roman shionogi affiliate sublicensees shall immediately cease development commercialization licensed product return amylin physical manifestation licensed technology amylin confidential information style margin margin bottom text indent font size font family time roman upon such termination shionogi agrees promptly transfer amylin including making such filing required with regulatory authority other governmental authority territory effect such transfer amylin request following with respect only licensed product nbsp ownership regulatory document regulatory approval applicable licensed product that controlled shionogi affiliate including regulatory document such time nbsp clinical including toxicology clinical study protocol data report applicable licensed product that possessed owned shionogi affiliate such time nbsp amylin sponsored investigator sponsored clinical trial result result ongoing clinical trial nbsp such other information data document applicable licensed product that owned shionogi affiliate that reasonably requested amylin permit amylin affiliate develop manufacture commercialize licensed product after termination date including limited document related prosecution maintenance defense enforcement licensed patent right style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman effective upon such termination shionogi will deemed have hereby granted amylin affiliate irrevocable royalty free fully paid exclusive fully transferable worldwide perpetual license with right grant sublicenses under intellectual property controlled shionogi effective date such termination including patent copyright trademark trade secret know that incorporates derived from licensed technology solely make have made sell offer sell import product containing leptin style margin margin bottom text indent font size font family time roman upon such termination request amylin shionogi agrees negotiate with amylin good faith sell transfer amylin inventory licensed product shionogi further agrees upon such termination request amylin negotiate good faith with amylin assign amylin contract with third party manufacturer supplier clinical trial organization clinical trial site related licensed product style margin margin bottom text indent font size font family time roman upon such termination party will cooperate good faith establish transition plan effectuate transfer contemplated under this section nbsp manner that preserve continuity clinical commercial supply with respect licensed product that being developed commercialized effective date termination style margin margin bottom text indent font size font family time roman upon termination this agreement shionogi under section nbsp solely shionogi nbsp shionogi shall have right retain license assignment granted amylin shionogi under this agreement nbsp payment after effective date such termination under this agreement shionogi shall terminate have further effect provided that shionogi undertakes continue royalty rockefeller amgen pursuant rockefeller license amgen agreement clarity forgoing shall limit shionogi right other remedy with respect such termination that available equity style margin margin bottom text indent font size font family time roman upon termination amylin pursuant section nbsp prior launch licensed product amylin agrees that shall continue supply either directly indirectly shionogi lead investigator kyoto university with drug substance drug product support clinical work style margin margin bottom text indent font size font family time roman survival following provision shall survive expiration termination this agreement article section termination this agreement shall relieve party liability which accrued hereunder prior effective date such termination preclude either party from pursuing right remedy have hereunder equity with respect breach default this agreement prejudice either party right obtain performance obligation remedy provided this article exclusive other remedy party have equity style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center miscellaneous style margin margin bottom text indent font size font family time roman entire agreement amendment this agreement including exhibit constitutes entire agreement between party their affiliate related subject matter hereof prior contemporaneous negotiation representation warranty agreement statement promise understanding related subject matter hereof superseded merged into extinguished completely expressed this agreement including exhibit party shall bound charged with written oral agreement representation warranty statement promise understanding specifically forth this agreement including exhibit effective date confidential disclosure agreement dated nbsp amended march nbsp between amylin shionogi confidentiality agreement hereby superseded this agreement provided that confidential information defined confidentiality agreement disclosed thereunder shall treated confidential information disclosed under subject term this agreement subsequent alteration amendment change addition this agreement shall binding upon party unless reduced writing signed authorized officer each party style margin margin bottom text indent font size font family time roman notice notice required permitted given under this agreement shall writing shall deemed have been sufficiently given purpose nbsp when delivered sent recognized overnight courier personally delivered nbsp upon confirmation receipt sent facsimile transmission provided duplicate hard copy promptly delivered other foregoing mean each case using mailing address party forth below such other mailing address which party notified pursuant this section style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign style text indent font size font family time roman nbsp shionogi valign bottom valign bottom style margin margin bottom font size font family time roman shionogi nbsp style margin margin bottom font size font family time roman doshomachi chome style margin margin bottom font size font family time roman chuo style margin margin bottom font size font family time roman osaka style margin margin bottom font size font family time roman japan style margin margin bottom font size font family time roman facsimile style margin margin bottom font size font family time roman attn general manager style margin margin bottom font size font family time roman corporate nbsp planning nbsp nbsp business nbsp development nbsp department valign bottom valign bottom style font size height height colspan height colspan style font family time roman font size valign style text indent font size font family time roman with nbsp nbsp copy nbsp valign bottom valign bottom style margin margin bottom font size font family time roman shionogi nbsp style margin margin bottom font size font family time roman doshomachi chome style margin margin bottom font size font family time roman chuo style margin margin bottom font size font family time roman osaka style margin margin bottom font size font family time roman japan style margin margin bottom font size font family time roman facsimile style margin margin bottom font size font family time roman attn nbsp general nbsp manager nbsp legal nbsp affairsdepartment valign bottom valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign style text indent font size font family time roman amylin valign bottom valign bottom style margin margin bottom font size font family time roman amylin pharmaceutical style margin margin bottom font size font family time roman towne centre drive style margin margin bottom font size font family time roman diego california style margin margin bottom font size font family time roman facsimile nbsp style margin margin bottom font size font family time roman attn nbsp vice nbsp president nbsp business nbsp development valign bottom valign bottom style font size height height colspan height colspan style font family time roman font size valign style text indent font size font family time roman with copy valign bottom valign bottom style margin margin bottom font size font family time roman amylin pharmaceutical style margin margin bottom font size font family time roman towne centre drive style margin margin bottom font size font family time roman diego california style margin margin bottom font size font family time roman facsimile nbsp style margin margin bottom font size font family time roman attn general counsel valign bottom valign bottom table style margin margin bottom text indent font size font family time roman governing judicial resolution this agreement shall governed construed accordance with state york applied agreement executed performed entirely within state york without regard applicable principle conflict each party hereto hereby irrevocably unconditionally consent submit exclusive jurisdiction court state york united state america located state york matter arising relating this agreement transaction contemplated hereby amylin defendant submit exclusive jurisdiction osaka district court japan matter arising relating this agreement transaction contemplated hereby shionogi defendant agrees commence litigation relating thereto except such court each party hereto hereby irrevocably unconditionally waif objection laying venue matter arising this agreement transaction contemplated hereby said court hereby further irrevocably unconditionally waif agrees plead claim such court that such matter brought such court been brought inconvenient forum party agree that final judgment such matter shall conclusive enforced other jurisdiction suit judgment other manner provided notwithstanding foregoing dispute controversy claim relating scope validity enforceability infringement patent right shall submitted exclusively competent court having jurisdiction over disputed patent style margin margin bottom text indent font size font family time roman limitation liability except liability breach obligation under article fraud comparable intentional misconduct neither party shall entitled recover from other party indirect special incidental consequential punitive damage connection with this agreement license granted hereunder limitation forth this section nbsp shall apply with respect either party indemnification obligation under section third party claim style margin margin bottom text indent font size font family time roman interpretation amylin shionogi have each participated negotiation diligence consulted their respective counsel regarding this agreement event ambiguity question intent interpretation arises this agreement shall construed drafted jointly party presumption burden proof shall arise favoring disfavoring party virtue authorship provision this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman assignment neither party assign transfer this agreement right obligation hereunder operation otherwise without prior written consent other party except that party make such assignment transfer operation otherwise without other party consent affiliate entity that acquires substantially business such party whether merger consolidation reorganization acquisition sale otherwise notwithstanding foregoing amylin shall have right assign right payment pursuant article without shionogi consent this agreement shall binding successor permitted assigns assigning party name party appearing herein shall deemed include name such party successor permitted assigns extent necessary carry intent this agreement assignment attempted assignment either party violation term this section nbsp shall null void legal effect style margin margin bottom text indent font size font family time roman performance affiliate each amylin shionogi acknowledge that obligation under this agreement performed affiliate amylin shionogi each amylin shionogi guarantee performance this agreement affiliate notwithstanding assignment affiliate accordance with section nbsp this agreement style margin margin bottom text indent font size font family time roman severability event that more provision contained herein application thereof circumstance held invalid illegal unenforceable respect reason party shall negotiate good faith with view substitution therefor suitable equitable provision order carry valid enforceable intent purpose such invalid provision provided however that validity legality enforceability such provision every other respect remaining provision contained herein shall impaired thereby being intended that right privilege party hereto shall enforceable fullest extent permitted style margin margin bottom text indent font size font family time roman heading heading each article section this agreement been inserted convenience reference only intended limit expand meaning language contained particular article section style margin margin bottom text indent font size font family time roman further action each party agrees execute acknowledge deliver such further instrument such other necessary appropriate order carry purpose intent agreement style margin margin bottom text indent font size font family time roman independent contractor relationship between shionogi amylin created this agreement solely that independent contractor this agreement create agency distributorship employee employer partnership joint venture similar business relationship between party neither party legal representative other party neither party assume create obligation representation warranty guarantee express implied behalf other party purpose whatsoever each party shall discretion shall have complete authoritative control over employee detail performing obligation under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman name right express implied granted shionogi this agreement manner trademark amylin affiliate shionogi shall allow representative name trademark amylin affiliate name their employee derivative thereof purpose promotion publicity advertising without amylin prior written consent which withheld amylin sole discretion shionogi amylin name extent included label attached vial amylin fill label accordance with performance forth section style margin margin bottom text indent font size font family time roman waiver party consent waiver express implied other party breach obligation hereunder shall deemed construed consent waiver other breach same other obligation other party party failure complain failure other party declare other party default insist upon strict performance obligation condition this agreement exercise right remedy consequent upon breach thereof matter long such failure continues shall constitute waiver such party right hereunder such breach other obligation condition party consent instance shall limit waive necessity obtain such party consent future instance event consent waiver shall effective purpose hereunder unless such consent waiver writing signed party granting such consent waiver style margin margin bottom text indent font size font family time roman expense regardless whether transaction contemplated this agreement consummated each party shall bear expense incurred connection with negotiation execution this agreement style margin margin bottom text indent font size font family time roman neither party shall have right amount owed such first party other party affiliate thereof under this agreement another agreement otherwise from amount owed such first party other party hereunder without prior written consent other party style margin margin bottom text indent font size font family time roman other right party acknowledge agree that except expressly forth this agreement neither party grant right license other party under this agreement shall either party have right obligation under this agreement style margin margin bottom text indent font size font family time roman party interest this agreement shall binding upon inure solely benefit each party hereto respective successor permitted assigns nothing this agreement express implied intended shall confer upon other person right benefit remedy nature whatsoever under reason this agreement with exception shionogi indemnitees amylin indemnitees under section respectively style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman rule construction this agreement term including cognate thereof such include includes mean including applicable cognate thereof without limitation word herein hereof hereunder other word similar import refer this agreement whole including exhibit particular section subsection paragraph subparagraph clause contained this agreement reference section exhibit mean those section this agreement exhibit attached this agreement except where otherwise stated style margin margin bottom text indent font size font family time roman counterpart this agreement executed nbsp more counterpart each which shall deemed original which together shall constitute same instrument style margin margin bottom text indent font size font family time roman precedence event conflict between this agreement exhibit attached hereto this agreement shall control style margin margin bottom text indent font size font family time roman witness whereof party have executed this agreement their duly authorized representative effective date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign colspan shionogi valign bottom valign bottom valign bottom valign bottom colspan amylin pharmaceutical style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman yasuhiro mino valign bottom valign bottom valign bottom valign bottom valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman mark nbsp gergen style font family time roman font size valign print nbsp name valign bottom valign bottom yasuhiro mino valign bottom valign bottom valign bottom valign bottom print nbsp name valign bottom valign bottom mark gergen style font family time roman font size valign title valign bottom valign bottom director board senior executive officer valign bottom valign bottom valign bottom valign title valign bottom valign nbsp vice nbsp president nbsp corporate nbsp development table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center protein sequence leptin style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center rockefeller patent right style margin margin bottom font size font family time roman part style margin margin bottom font size font family time roman attached list rockefeller patent style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom docket number valign bottom nbsp nbsp valign bottom application number valign bottom nbsp valign bottom title valign bottom nbsp valign bottom country valign bottom nbsp nbsp valign bottom application date valign bottom nbsp valign bottom status valign bottom nbsp nbsp valign bottom patent number valign bottom nbsp valign bottom status valign bottom nbsp nbsp valign bottom grant date valign bottom nbsp valign bottom expiry date style font size height height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom japan valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom granted valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom granted valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom style font size height height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom japan valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom granted valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom granted valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom style font size height height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom japan valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom granted valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom granted valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom style font size height height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign valign bottom nbsp valign valign bottom nbsp valign bottom korea south valign bottom nbsp nbsp valign valign bottom nbsp valign granted valign bottom nbsp nbsp valign valign bottom nbsp valign granted valign bottom nbsp nbsp valign valign bottom nbsp valign table style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center leptin patent right style margin margin bottom font size font family time roman part style margin margin bottom font size font family time roman attached list leptin patent right style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom docket number valign bottom nbsp nbsp valign bottom application number valign bottom nbsp valign bottom title valign bottom nbsp valign bottom country valign bottom nbsp nbsp valign bottom application date valign bottom nbsp valign bottom status valign bottom nbsp nbsp valign bottom patent number valign bottom nbsp nbsp valign bottom status valign bottom nbsp nbsp valign bottom grant date valign bottom nbsp nbsp valign bottom expiry date style font size height height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom japan valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom filed valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom pending valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center this exhibit been redacted subject style margin margin bottom font size font family time roman align center confidential treatment request redacted material marked style margin margin bottom font size font family time roman align center with been filed separately with security style margin margin bottom font size font family time roman align center exchange commission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center amgen agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center body html text document